Cytosorbents (CTSO): Rolling Valuation To 2018 - Maxim
Tweet Send to a Friend
Maxim Group analyst, Gabrielle Zhou, reiterated her Buy rating on shares of CytoSorbents (NASDAQ: CTSO) and raised her price target ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


